Publication
Upcoming Issue: Spring 2013
The upcoming issue will be discussing health policy issues concerning the pharmaceutical industry.
Recent Blog Posts
As U.S. health care costs continue to increase, the cost of prescription drugs are often a topic of debate surrounding health care reform discussions. Last
With HIV infection rates persisting at high levels in the United States, it’s time we faced the facts. Science and policy are disconnected. In the United States, the sharing of contaminated needles during injection drug use accounts for 7-14% of new HIV infections each year.
Quick Contact
A Publication of the Harvard Interfaculty Initiative in Health Policy
Copyright � 2013 Harvard Health Policy Review